Raymond Sanchez

WORK HISTORY

EDUCATION

ABOUT RAYMOND SANCHEZ

Raymond Sanchez, MD was the Chief Medical Officer of Cerevel Therapeutics focused on the global development of novel and innovative treatments in CNS until 9 August 2024 when Cerevel was acquired by AbbVie. He is now a Senior Advisor at Bain Capital Life Sciences as well as a Board member and Scientific Advisory member for several organizations. He is a psychiatrist with over twenty years of academic, medical and pharmaceutical industry experience. Ray has a proven history of global asset development resulting in regulatory approvals in multiple indications and formulations in compounds such as Abilify, Abilify Maintena and Rexulti, including the first FDA approved small molecule/digital combination therapy to monitor ingestion, Abilify MyCite. Ray has provided transformative executive leadership overseeing global development portfolios from early phase to late-stage programs with specific innovative study designs having significant global business impact. He has a strong global network of academic and regulatory experts with a history of effective collaboration and outcomes. He has extensive business development experience with due diligence of potential assets and alliance acquisitions and management. In 2019, Ray partnered with Bain Capital Life Sciences in building Cerevel Therapeutics with other seasoned executives that led to an IPO in 2020. Ray was inducted as a member of the Neuroscience Forum of the Academies of Science, Engineering and Medicine. He is also the recipient of the \'Top 100 Leaders in Healthcare\' award by the International Forum on Advancements in Healthcare (IFAH) as well as one of the Pharma Leaders by Pharmaceutical Executive magazine. In 2023, Ray was named to the PharmaVoice 100, acknowledging his significant contributions to the Life Sciences as a clinical innovator. He has also served as Executive Chairman of the International Society for CNS Drug Development (ISCDD). He is on the Board of Directors of the Connecticut Mental Health Center Foundation-Yale School of Medicine and the Life Re-Entry Foundation as well as other non-for-profit organizations. He is well-published and has participated in numerous scientific presentations. Ray trained in Psychiatry at the Yale School of Medicine where he was appointed as Chief Resident and an Instructor before joining the Life Sciences Industry.